Results 31 to 40 of about 1,788 (174)

European guideline and expert statements on the management of narcolepsy in adults and children [PDF]

open access: yes, 2021
Background and purpose: Narcolepsy is an uncommon hypothalamic disorder of presumed autoimmune origin that usually requires lifelong treatment. This paper aims to provide evidence-based guidelines for the management of narcolepsy in both adults and ...
Baldin, Elisa   +17 more
core   +11 more sources

Gamma hydroxybutyrate (GHB), gamma butyrolactone (GBL) and 1,4 butanediol (1,4-BD; BDO) : a literature review with a focus on UK fatalities related to non-medical use [PDF]

open access: yes, 2015
Misuse of gamma hydroxybutrate (GHB) and gamma butyrolactone (GBL) has increased greatly since the early 1990s, being implicated in a rising number of deaths.
Abanades   +324 more
core   +1 more source

Why dried blood spots are an ideal tool for CYP1A2 phenotyping [PDF]

open access: yes, 2014
Background and Objective: Dried blood spot (DBS) sampling has gained wide interest in bioanalysis during the last decade and has already been successfully applied in pharmacokinetic and phenotyping studies.
De Kesel, Pieter   +2 more
core   +2 more sources

Pain-related diseases and sleep disorders [PDF]

open access: yes, 2012
Pain and sleep share mutual relations under the influence of cognitive and neuroendocrine changes. Sleep is an important homeostatic feature and, when impaired, contributes to the development or worsening of pain-related diseases.
Roizenblatt, Marina   +3 more
core   +4 more sources

Changes in Cataplexy Frequency in a Clinical Trial of Lower-Sodium Oxybate with Taper and Discontinuation of Other Anticataplectic Medications [PDF]

open access: yes, 2022
Correction:Background Lower-sodium oxybate (LXB) is an oxybate medication with the same active moiety as sodium oxybate (SXB) and a unique composition of cations, resulting in 92% less sodium.
Black, Jed   +10 more
core   +2 more sources

Narcolepsy 2025 (with an Australasian perspective). [PDF]

open access: yesIntern Med J
Abstract Narcolepsy is a disorder of central hypersomnolence, which, while uncommon, can carry profound implications for affected individuals. Despite this, it remains under‐recognised within the medical community and presents frequent diagnostic and treatment challenges in the Australasian setting.
Lin A, Yee BJ, Tai JE, Sivam S.
europepmc   +2 more sources

Central neuropathic pain in paraplegia alters movement related potentials [PDF]

open access: yes, 2018
Objectives: Spinal Cord Injured (SCI) persons with and without Central Neuropathic Pain (CNP) show different oscillatory brain activities during imagination of movement.
Fraser, Matthew   +4 more
core   +1 more source

Nocturnal sodium oxybate increases the anterior cingulate cortex magnetic resonance glutamate signal upon awakening [PDF]

open access: yes, 2023
Clinical guidelines recommend sodium oxybate (SXB; the sodium salt of γ-hydroxybutyrate) for the treatment of disturbed sleep and excessive daytime sleepiness in narcolepsy, yet the underlying mode of action is elusive.
Baur, Diego Manuel   +9 more
core   +1 more source

Misdiagnosis of narcolepsy [PDF]

open access: yes, 2016
BACKGROUND: Narcolepsy is a chronic primary sleep disorder, characterized by excessive daytime sleepiness and sleep dysfunction with or without cataplexy.
American Academy of Sleep Medicine   +19 more
core   +3 more sources

Patients' perspective of the effectiveness and acceptability of pharmacological and non-pharmacological treatments of fibromyalgia. [PDF]

open access: yes, 2018
Background and aims Fibromyalgia is a complex condition characterised by widespread pain, sleep disturbance, fatigue and cognitive impairment, with a global mean prevalence estimated at 2.7%.
Ashe, Simon   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy